Replicate Bioscience, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Replicate Bioscience, Inc.
Quantité totale PI 40
Rang # Quantité totale PI 35 840
Note d'activité PI 2,6/5.0    46
Rang # Activité PI 15 922
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

14 1
10 0
15 0
0
 
Dernier brevet 2025 - Modified western equine encephal...
Premier brevet 2021 - Modified chikungunya viruses and...
Dernière marque 2021 - REPLICATE
Première marque 2021 - REPLICATE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions and methods for inducing immune response against epstein-barr viruses. e.ge.g., self...
Invention Compositions and methods for expression of egfr. The present disclosure relates to modified viral...
Invention System and method for cardiopulmonary bypass using hypobaric oxygenation. A system for cardiopul...
Invention Compositions and methods for expression of il-1ra and il-18bp. The present disclosure relates to ...
Invention Methods for identification and selection of self-replicating rna molecules for biomedical applica...
2023 Invention Modified madariaga viruses, self-replicating rna constructs, and uses thereof. The present disclo...
Invention Modified madariaga viruses, self-replicating rna constructs, and uses thereof
Invention Modified western equine encephalitis viruses and uses thereof. The present disclosure relates to...
Invention Modified western equine encephalitis viruses and uses thereof. The present disclosure relates to ...
Invention Modified western equine encephalitis viruses and uses thereof
Invention Compositions and methods for the prevention and treatment of rabies virus infection. The present...
Invention Compositions and methods for the prevention and treatment of rabies virus infection. The present ...
Invention Compositions and methods for the prevention and treatment of rabies virus infection
Invention Methods for generating functional self-replicating rna molecules. The present disclosure relates...
Invention Methods for generating functional self-replicating rna molecules. de novode novo functional srRNA...
Invention Methods for generating functional self-replicating rna molecules
2022 Invention Compositions and methods for expression of il-12 and il-1ra. The present disclosure relates to t...
Invention Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responses. The present d...
Invention Methods of generating self-replicating rna molecules. The present disclosure generally relates t...
Invention Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responses. The present di...
Invention Methods of generating self-replicating rna molecules. The present disclosure generally relates to...
Invention Modified alphaviruses with heterologous nonstructural proteins. The present disclosure relates t...
Invention Modified alphaviruses with heterologous nonstructural proteins. e.g.e.g., self-replicating RNAs),...
Invention Modified alphaviruses with heterologous nonstructural proteins. The present disclosure relates to...
Invention Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof. ...
Invention Alphavirus vectors containing universal cloning adaptors. The present disclosure relates to the ...
Invention Alphavirus vectors containing universal cloning adaptors. e.ge.g., self-replicating RNAs), pharma...
2021 P/S Pharmaceutical and biologic preparations for the treatment of cancer, autoimmune disorders and di...
Invention Compositions and methods for expression of il-12 and il-1ra. The present disclosure relates to th...
Invention Modified chikungunya viruses and sindbis viruses and uses thereof. The present disclosure relate...
Invention Modified chikungunya viruses and sindbis viruses and uses thereof. The present disclosure relates...